Individual holder
MCLEAY MATTHEW T
US·3 granted patents·3 pending applications·9 citations·filing 2009–2025
Individually held — no corporate assignee on record.
Top patents by PatentIndex Score
6 records- 0187US2026034097A1Compositions containing verteporfin, ribavirin, gemcitabine, or combinations thereof and methods of use for treating covid-19, cancer, or non cancer diseasesMCLEAY MATTHEW T·Filed 2025·Application pending·0 cites
- 0285US12083178B2Anti-fibroblastic fluorochemical emulsion therapiesMCLEAY MATTHEW T·Filed 2019·Granted Sep 10, 2024·2 cites·20 claims
- 0380US2026053779A1Compositions containing verteporfin, ribavirin, gemcitabine, or combinations thereof and methods of use for treating covid-19, cancer, or non cancer diseasesMCLEAY MATTHEW T·Filed 2025·Application pending·0 cites
- 0479US10543273B2Anti-fibroblastic fluorochemical emulsion therapiesMCLEAY MATTHEW T·Filed 2016·Granted Jan 28, 2020·3 cites·16 claims
- 0577US9351943B2Anti-fibroblastic fluorochemical emulsion therapiesMCLEAY MATTHEW T·Filed 2011·Granted May 31, 2016·4 cites·10 claims
- 0666US2010297033A1Megaribavirin alone or combination of other antiviral, antioxidant and a perflubron emulsion for treatment of viral diseaseMCLEAY MATTHEW T·Filed 2009·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when MCLEAY MATTHEW T files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →